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The present study was conducted to evaluate the safety profile of Janma Ghunti Honey in Wistar rats on oral 
administration for 28 consecutive days. Animals were randomized on the basis of body weight into 6 groups. Three groups 
received test item (TI) at three different dose levels (3 mL/k g, 6 mL/kg and 12 mL/kg body weight). One group served as 
high dose satellite reversal group (12 mL/kg). One group each served as the control and satellite control group. Animals 
were observed for clinical signs of toxicity and mortality at least once daily. Animals from satellite groups were observed 
for further 14 days without treatment to evaluate delayed occurrence or reversibility of any signs/toxicity. At the end of the 
study, animals were studied through clinical pathology and necropsy examination. No treatment related mortality was 
observed in any group. Except in female low dose and female high dose satellite groups, all the treated groups exhibited 
weight gain and no statistically significant alterations were observed. No TI related toxicity was found on hematological 
investigation, blood biochemistry parameters and absolute and relative organ weights among treated groups. 'No Observed 
Adverse Effect Level' of TI in male and female Wistar rats was found to be above 12 mL/kg body weight. 
Keywords: Janma Ghunti Honey, Sub chronic toxicity, Wistar rats 
IPC Code: Int Cl.21: A61K 9/00, A61K 35/644, A61K 36/00, A61K 45/06, A62D 3/00 
Janma Ghunti Honey is a Poly-herbal Ayurvedic 
formulation for maintenance of the overall digestive 
health of babies. It comprises ingredients like Phalgu 
(Ficus carica), Draksha (Vitis vinifera), Vidanga 
(Embelia ribes Burm.f.), Amaltas (Cassia fistula L.), 
Senna (Cassia angustifolia) and Vacha (Acorus 
calamus) etc. that are traditionally used in Ayurveda 
with added benefits of honey. By virtue of its 
ingredients, Janma Ghunti acts as an effective 
remedy for stomach ailments such as flatulence, 
constipation and stomach ache and helps 
improve digestion (Table 1). The antihistaminic 
and intestinal motility efficacy of the Janma 




In the current study, the sub-chronic safety profile 
of Janma Ghunti was investigated via., 28-day 
repeated dose oral administration to Wistar rats. The 
study followed ―OECD Guideline for testing of 
chemicals, Guideline 407- ―Repeated Dose 28 Day 




Study compliance and ethical approvals 
This study was conducted in compliance with 
OECD Environmental Health and Safety Publications, 
Series on Principles of Good Laboratory Practice and 
Compliance Monitoring No. 1. ENV/MC/CHEM 
(98)17 at the animal facility registered and compliant
with CPCSEA [Committee for the Purpose of
Control and Supervision of Experiments on Animals
(CPCSEA registration no. 64/PO/Br/s/99/CPCSEA)],
Ministry of Environment and Forest, Govt. of India.
Study was prior approved by the Institutional Animal
Ethics Committee (Approval No. IAEC/27/274 dated
26JUN2013).
Chemicals/reagent/media 
Formaldehyde (Rankem), isofluorine (Raman & 
Weil Pvt. Ltd.), sodium phosphate (Diabasic) 
(SDFCI), sodium phosphate (Monobasic) (Rankem/ 
RFCL Ltd.), isopropyl alcohol (Rankem/RFCL Ltd.), 
xylene (Finar Limited), Paraffin Wax (D K Lab 
Solutions), hematoxylin (Merck) & eosin (Fischer 
Scientific). —————— 
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Wistar rats, male and female, less than 9 weeks of 
age at time of dosing in weight ranges of 96.22 to 
154.00 g (male) and 97.68 to 147.52 g (Female) 
obtained from Animal Facility, LUVAS, Hisar, were 
used in this study. 
 
Husbandry practices  
Animals up to five per cage were housed in 
polypropylene cages and acclimatized (6 days male & 
7 days for female, temperature 21.3-24.2°C, relative 
humidity: 42%-61%, 12h/D cycle). The room 
temperature and relative humidity were recorded daily 
using a temperature data logger. Throughout the 
study, the rats were given unlimited supply of 
Reverse Osmosis (RO) water and fed conventional 
pellet diet (Golden Feeds, New Delhi).  
 
Test item 
Janma Ghunti Honey (DRDC/2014/028) was 
obtained from Dabur India Ltd. as brown coloured 
syrup; Batch No. 61025, Mfd: August 2014 with 
expiry 3 years from the date of manufacture was used 
in this study. It was stored at room temperature. 
 
Preparation of test item 
Considering the strength 300 mg was present in  
1 Ml of Janma Ghunti Honey (TI). The TI was in 
ready to use form and used as such. 
 
Dose levels 
Three dose levels: namely, low dose (3 mL/kg 
bwt.), mid dose (6 mL/kg b.wt.) and high dose  
(12 mL/kg b.wt.) were used. The dosage was based on 
human therapeutic dose (1.5 g/5 mL day) converted to 
rat dose applying standard conversion factor 
considering human body weight (60 kg) by allometric 
method. + 
 
Randomization & dose administration  
Animals were randomized to six (G1-G4, G1S & 
G4S) groups [5 male & 5 females in G1-G4 & 10 
animals each (5 male & 5 female) in G1S & G4S] 
before initiation of experiment, on the basis of body 
weight. The test item was administered orally to 
animals of the groups G2, G3, G4 and G4S once daily 
for 28 consecutive days using disposable syringes  
(2 mL /5 mL) with an oral gavage needle (18 gauge). 
Rats in the control group received only Milli-Q  
water in G1 and G1S at a dose volume of  
20 mL/kg BW. 
 
Observations 
Clinical sign and mortality 
Daily observation of study animals was done for any 
clinical signs of toxicity and twice for morbidity and 
mortality. Feed consumption and behavioral 
examination such as posture, convulsion (home  
cage observation), ease of removing and  
handling reactivity/skin/piloerection/palpebral closure/ 
lacrymation/ salivation, etc. (handling observation) and 
open field observation like arousal, respiration, 
movements, etc were performed at weekly intervals.  
Ophthalmic examination was done before and after 
the study. Before termination during the fourth week 
for the main group and on the sixth week for recovery 
satellite group, they were tested for various sensory 
reactivity and motor activity assessment.  
 
Laboratory parameters 
Hematological and biochemical estimations were 
performed for animals in treatment groups (G2 to G4) 
while animals of satellite groups (G1S & G4S) were 
tested after the end of reversal period. Blood samples 
were collected from anesthetized animals after overnight 
fasting from the retro-orbital sinus using capillaries.  
 
Hematology and biochemistry 
Hematological tests included complete hemogram 
with hemoglobin, cell counts and blood clotting time. 
Biochemical testing included tests like blood glucose, 
liver function tests, renal function tests, lipid and total 
proteins.  
Table 1 — Summary of Mortality 
GROUP DOSE (ML/KG B. WT.) 
NO. OF ANIMAL MORTALITY 
MALE FEMALE MALE FEMALE TOTAL % MORTALITY 
G1 CONTROL 5 5 0 0 0 0 
G2 3 5 5 1 0 1 10 
G3 6 5 5 1 0 1 10 
G4 12 5 5 0 1 1 10 
G1S CONTROL SATELLITE 5 5 1 0 1 10 
G4S 12 5 5 1 1 2 20 





Test and control animals were sacrificed on Day 29 
of study. Animals in satellite groups were sacrificed 
14 days later. External surface, orifices and cavities of 
body were examined under necropsy. Content organs 
and tissues of cavities viz., eye, brain, adrenal, heart, 
testes/ovaries, epididymis/uterus, kidneys, liver, 
lungs, spleen, spinal cord, trachea, thymus, stomach, 
duodenum, jejunum, colon, thigh muscle, lymph 
node, urinary bladder, prostate & seminal vesicles 
were examined. Adrenal, brain, heart, testes/ovaries, 
epididymis/uterus, kidneys, liver, thymus and spleen 
were weighed and recorded. The relative organ 
weights were calculated using the formula = {(organ 
weight/body weight) x100}. The organs collected 
were preserved using 10% formalin solution. The 
modified Davidson’s fixative was used to preserve 
testes and eyes. 
 
Histopathological examination 
The organs and tissues preserved during necropsy 
were processed by paraffin embedding. Sample 
sections of 6 µM thickness were examined after 
hematoxylin staining and eosin dyeing as per standard 
methodology. Except for satellite group animals, 




Data on feed consumption, body and organ 
weights, hematologic and biochemical analyses were 
analyzed for differences among treated/control groups 
using One-way ANOVA Dennett multiple and  
Two-way ANOVA Bonferroni post-tests and t tests 
(and nonparametric tests) with the help of the 
software GraphPad Prism, version 4.01. Significance 
was considered at p<0.05 with 5% significance level.  
 
Results and Discussion 
General health status and mortality 
Out of 60 animals, total six mortalities (G2-1/10; 
G3-1/10; G4-1/10; G1S-1/10 and G4S-2/1 0) were 
observed during the study. One male (rat no. 13) from 
G2 and one male (rat no. 25) from G3 were found 
dead on day 1 of dosing. One female (rat no. 39) from 
G4 and one male (rat no. 53) from G4S were found 
dead on day 4 and 2 of dosing, respectively. These 
animals were necropsied immediately post death and 
the mortalities were found to be due to inadvertent 
dose administration of TI in trachea instead of 
esophagus. 
Rat No. 41 male from satellite control group 
treated with vehicle (Milli Q water) exhibited clinical 
sign such as nostril discharge (from days 24 to 26) 
and swelling in upper thoracic region (from day 25 to 
26) and was found dead on day 27. 
Animal No. 56 female from high dose satellite 
group treated with TI at 12 mL/kg body weight 
showed clinical signs such as swelling in left 
forelimb, abdominal breathing (on day 08), kyphosis 
(animal sitting in a position of humpback) and 
morbidity on day 9. The animal was found dead on 
day 9 of dosing. Necropsy examination (gross 
pathology) of both these animals revealed pus in the 
thoracic region and esophagus which might be due to 
inadvertent dose administration procedure. Based on 
the above findings, all the six mortalities were not 
considered as test item related and might be 
considered as accidental death and not attributed to 
treatment of test item. 
Rest of the animals from all the groups were found 
normal throughout the study period except one female 
from G2 (rat no. 16) which showed ptosis from days 
22 to 29. Since this clinical sign was observed in one 
animal only from low dose, it may not be considered 
as a treatment related effect (Table 1). 
 
Feed consumption 
Mean values of the feed consumption in treatment 
groups including satellite groups were not statistically 
significant when compared with their controls  
except males from high dose group (G4) showed 
significant increase during week 2. However, this  
was considered incidental since this finding was 
inconsistent and absent in high dose satellite  
group (Fig. 1a-d). 
 
Body weights 
Male and female animals from all the treated 
groups including the satellite group exhibited body 
weight gain during the study. No statistically 
significant alterations were observed except in 
females from low dose group which showed 
significant (p<0.05) decrease on week 0 (day of 
dosing prior to administration of Tl) and week 1 and  
2 when compared with control group. Female rats 
from high dose satellite (G4S) also showed significant 
decrease (p<0.05) in body weight during week 6 when 
compared with satellite control group G1S. The 
change in body weight was not considered an effect of 
TI as the alteration was not in dose dependent manner 
or absence in another sex (Fig. 2a-2d). 






Fig. 1 a-d — Effect of sub-acute administration of Janma Ghunti for 
28 days on feed consumption of male and female rats. Data are 
expressed as Mean±Standard Deviation (*Significant value 
(p<0.05). (a) Feed Consumption – Males, (b) Feed Consumption – 
Females, (c) Feed Consumption (g/animal/week) - Satellite Male 
& (d) Feed Consumption (g/animal/week) - Satellite Female 
 
Hematological investigations 
Evaluation of hematological parameters in terminal 
sacrificed male rats showed increase in neutrophils 
(G4) and decrease in lymphocytes (G4), hemoglobin 
(G2 and G4), PCV (G2), MCH (G2 and G4), MCHC 
(G2, G3 and G4) and platelet count (G2). Female rats 
revealed decrease in TLC and MCH value (G4). 
Above changes were observed to be statistically 
significant at p<0.05 or at p<0.01 level. Changes 
observed were inconsistent, not in a dose dependent 
manner or absent in satellite groups, hence considered 
as incidental finding (Table 2a-d). 
 
 
Fig. 2a-d — Effect on body weight. T(a)– Male, (b)– Female,  
(c)- Satellite Male & (d)- Satellite Female 
 
Blood biochemistry  
Evaluation of blood biochemistry in male rats 
showed statistical increase in ALP (G3, G4 and G4S) 
and decrease total cholesterol (G4), BUN (G2 and 
G4), phosphorous (G2 and G4) and triglycerides 
(G4S) group. Female rats revealed statistically 
significant increase in ALP (G4), chloride (G3) and 
total Bilirubin (G4S) and decrease total cholesterol 
(G4S). The above changes were observed to be 
statistically significant at p<0.05, p<0.01 level. The 
changes observed in the above parameters were 
inconsistent or not in a dose dependent manner and 
hence were considered incidental findings. The 
significant levels are expressed in (Table 3a-d).  
 
Organ weights and relative organ weights 
Absolute organ weights and relative organ weights 
of animals in treated and satellite groups were 
comparable with respective control groups and found 
to be nonsignificant except absolute male organ that 
revealed statistical increase in weight of heart and 
spleen from  low  dose  (G2)  whereas  in  females,  it  





Table 2a — Summary of Hematology Parameters- MALE 
PARAMETER 
GROUP MEAN VALUE 
G1 G2 G3 G4 
CONTROL 3 ML/KG B. WT. 6 ML/KG B. WT. 12 ML/KG B. WT. 
MEAN SEM MEAN SEM MEAN SEM MEAN SEM 
TLC (K/UL) 6.53 0.23 6.29 0.32 6.50 1.68 4.00 0.34 
NEUTROPHIL (%) 17.34 1.58 18.62 3.29 25.85 5.12 36.14 ↑ 6.24 
LYMPHOCYTE (%) 66.08 1.72 62.05 6.93 57.20 5.03 43.28↓ 5.60 
MONOCYTE (%) 8.30 0.48 10.71 2.50 9.31 1.51 13.10 1.70 
EOSINOPHIL (%) 3.11 0.62 2.71 0.54 2.59 0.60 2.60 0.70 
BASOPHIL (%) 5.18 0.57 5.89 1.61 5.05 0.79 4.87 0.47 
RBC (M/UL) 7.59 0.11 6.98 0.35 7.27 0.17 7.16 0.16 
HEMOGLOBIN (G/DL) 14.26 0.21 12.55↓↓ 0.58 13.25 0.28 12.86↓ 0.24 
PCV (%) 41.32 0.49 37.25↓ 1.65 39.23 0.79 38.26 0.62 
MCV (FL) 54.46 0.30 53.43 0.65 53.98 0.84 53.42 0.37 
MCH(PG)  18.78 0.10 17.98↓↓ 0.17 18.23 0.25 17.96↓↓ 0.13 
MCHC (G/DL) 34.50 0.09 33.63↓↓ 0.17 33.78↓↓ 0.17 33.60↓↓ 0.13 
PLATELET COUNT (K/UL) 935.20 44.32 558.75↓↓ 108.36 907.75 87.07 967.60 31.11 
VALUES ARE IN MEAN  SEM, ↑=INCREASED SIGNIFICANT AT P<0.05, ↓=DECREASED SIGNIFICANT AT P<0.05, 
↓↓=DECREASED SIGNIFICANT AT P<0.01 
 
 
Table 2b — Summary of Hematology Parameters-SATELLITE GROUPS-MALE 
PARAMETER 
GROUP MEAN VALUE - MALE 
G1S G4S 
CONTROL 12 ML/KG B. WT. 
MEAN SEM MEAN SEM 
TLC (K/UL) 7.37 0.73 7.15 0.43 
NEUTROPHIL (%) 32.00 6.13 20.98 2.08 
LYMPHOCYTE (%) 47.08 4.20 55.78 2.60 
MONOCYTE (%) 11.11 2.02 11.38 2.05 
EOSINOPHIL (%) 3.71 0.91 4.11 0.84 
BASOPHIL (%) 6.13 1.36 7.76 0.34 
RBC (M/UL) 8.07 0.24 7.93 0.12 
HEMOGLOBIN (G/DL) 14.38 0.40 14.08 0.23 
PCV (%) 42.68 0.98 41.55 0.64 
MCV (FL) 52.90 0.62 52.40 0.98 
MCH(PG)  17.83 0.21 17.75 0.32 
MCHC (GM/DL) 33.68 0.19 33.90 0.13 
PLATELET COUNT (K/UL) 825.50 33.00 899.75 71.28 
VALUES ARE IN MEAN  SEM 
 
Table 2c — Summary of Hematology Parameters-FEMALE 
PARAMETER 
GROUP MEAN VALUE – FEMALE 
G1 G2 G3 G4 
CONTROL 3 ML/KG B. WT. 6  ML/KG B. WT. 12 ML/KG B. WT. 
MEAN SEM MEAN SEM MEAN SEM MEAN SEM 
TLC (K/UL) 7.34 0.69 5.65 0.49 5.55 0.49 4.66↓ 0.50 
NEUTROPHIL (%) 25.10 2.32 27.10 1.63 33.32 9.20 26.45 6.56 
LYMPHOCYTE (%) 52.94 2.05 51.92 2.64 44.40 9.70 53.83 6.72 
MONOCYTE (%) 9.16 0.39 8.70 1.42 9.64 0.70 8.65 1.76 
EOSINOPHIL (%) 6.58 0.71 7.20 0.94 7.31 1.21 5.45 2.00 
BASOPHIL (%) 6.20 0.14 5.08 0.81 5.31 0.59 5.66 0.59 
RBC (M/UL) 7.03 0.18 6.84 0.19 6.81 0.14 6.85 0.14 
HEMOGLOBIN (G/DL) 13.20 0.28 12.66 0.23 12.46 0.34 12.35 0.20 
PCV (%) 38.46 0.81 37.26 0.71 36.92 0.94 36.33 0.45 
MCV (FL) 54.80 0.65 54.50 0.70 54.20 0.63 53.10 0.63 
MCH(PG)  18.78 0.16 18.50 0.20 18.28 0.17 18.08↓ 0.14 
MCHC (GM/DL) 34.28 0.14 33.98 0.15 33.78 0.16 34.05 0.22 
PLATELET COUNT (K/UL) 908.40 29.56 908.40 19.88 904.20 56.87 1021.50 57.20 










Table 2d — Summary of Hematology Parameters-SATELLITE GROUPS-FEMALE 
PARAMETER 
GROUP MEAN VALUE - FEMALE 
G1S G4S 
CONTROL 12 ML/KG B. WT. 
MEAN SEM MEAN SEM 
TLC (K/UL) 7.33 0.50 9.14 0.87 
NEUTROPHIL (%) 29.14 2.24 31.03 2.94 
LYMPHOCYTE (%) 47.04 1.80 44.85 3.78 
MONOCYTE (%) 10.92 1.21 10.41 0.76 
EOSINOPHIL (%) 7.44 1.00 8.04 1.01 
BASOPHIL (%) 5.46 0.78 5.69 0.91 
RBC (M/UL) 7.59 0.20 7.05 0.38 
HEMOGLOBIN (G/DL) 13.66 0.40 12.68 0.49 
PCV (%) 39.94 1.13 37.68 1.58 
MCV (FL) 52.62 0.64 53.48 0.78 
MCH(PG)  17.98 0.16 18.05 0.32 
MCHC (GM/DL) 34.24 0.14 33.73 0.17 
PLATELET COUNT (K/UL) 932.00 40.16 880.25 25.47 
VALUES ARE IN MEAN  SEM 
 
Table 3a — Summary of Biochemistry Parameters: Male Animals 
Parameter 
G1 G2 G3 G4 
Control 3 mL/kg b. wt. 6 mL/kg b. wt. 12 mL/kg b. wt. 
Mean SEM Mean SEM Mean SEM Mean SEM 
Blood Glucose (mg/dL) 105.47 5.67 120.08 8.74 114.65 14.04 131.10 5.69 
Total Cholesterol (mg/dL) 61.67 8.58 44.31 4.13 42.55 3.13 40.06↓ 1.85 
Triglyceride (mg/dL) 64.20 11.15 60.01 4.32 38.35 7.02 45.59 12.09 
BUN (mg/dL) 27.33 1.47 19.04↓↓ 0.34 25.61 1.68 15.92↓↓ 2.05 
Creatinine (mg/dL) 0.61 0.03 0.55 0.01 0.60 0.01 0.57 0.02 
Total Bilirubin (mg/dL) 0.20 0.07 0.31 0.05 0.23 0.06 0.27 0.01 
SGOT (IU/L) 103.19 3.59 101.54 2.78 95.22 6.59 94.30 2.16 
SGPT (IU/L) 40.19 2.55 35.61 2.70 44.21 3.78 36.14 1.05 
ALP (U/L) 227.86 32.96 335.93 27.50 343.93↑ 29.72 349.55↑ 24.54 
Total Protein (gm/dL) 6.55 0.20 6.41 0.11 6.59 0.16 6.18 0.10 
Albumin (gm/dL) 4.12 0.09 3.99 0.07 4.10 0.04 3.97 0.06 
Calcium (mg/dL) 11.25 0.20 11.28 0.19 11.42 0.17 11.28 0.25 
Phosphorus (mg/dL) 6.83 0.30 5.33↓ 0.17 6.67 0.19 4.82↓↓ 0.41 
Sodium (m Eq/l) 149.60 0.81 149.75 0.63 151.50 0.29 150.60 0.24 
Potassium (m Eq/l) 4.58 0.12 4.63 0.15 5.30 0.49 5.10 0.23 
Chloride (m Eq/l)  110.00 0.77 111.50 0.65 111.75 0.95 111.00 0.89 
Values are in Mean  SEM; ↑=Increased Significant at p<0.05, ↓↓=Decreased Significant at p<0.01, ↓=Decreased Significant at p<0.05 
 
 
Table 3b — Summary of Biochemistry Parameters: Male Animals Satellite Group 
Parameter 
Group Mean Values - Male 
G1S G4S 
Control 3 ml/kg bw 
Mean SEM Mean SEM 
Blood Glucose (mg/dL) 132.19 7.87 109.56 10.06 
Total Cholesterol (mg/dL) 50.07 12.65 69.19 7.61 
Triglyceride (mg/dL) 66.55 2.90 37.06↓ 3.60 
BUN (mg/dL) 30.41 5.91 29.27 0.96 
Creatinine (mg/dL) 0.59 0.02 0.59 0.01 
Total Bilirubin (mg/dL) 0.79 0.08 0.59 0.02 
SGOT (IU/L) 91.12 4.05 93.93 2.26 
SGPT (IU/L) 47.27 1.76 41.49 2.02 
ALP (U/L) 334.74 13.83 427.94↑ 20.73 
Total Protein (gm/dL) 6.87 0.15 6.71 0.16 
Albumin (gm/dL) 4.13 0.10 4.15 0.06 
Calcium (mg/dL) 12.03 0.20 11.88 0.15 
Phosphorus (mg/dL) 7.22 0.69 7.08 0.18 
Sodium (m Eq/l) 151.75 0.63 152.00 0.82 
Potassium (m Eq/l) 4.30 0.27 4.45 0.19 
Chloride (m Eq/l)  110.75 0.85 111.25 0.85 
Values are in Mean  SEM;↑=Increased Significant at p<0.05, ↓=Decreased Significant at p<0.05 




Table 3c — Summary of Biochemistry Parameters: Female Animals 
Parameter 
Group Mean Values - Female 
G1 G2 G3 G4 
Control 3 mL/kg b. wt. 6 mL/kg b. wt. 12 mL/kg b. wt. 
Mean SEM Mean SEM Mean SEM Mean SEM 
Blood Glucose (mg/dL) 105.51 1.87 103.62 6.80 110.66 6.59 99.16 5.27 
Total Cholesterol (mg/dL) 56.76 3.93 52.84 2.09 52.11 3.58 50.42 1.50 
Triglyceride (mg/dL) 52.90 7.89 39.94 4.49 37.82 2.55 46.47 5.99 
BUN (mg/dL) 29.53 0.80 31.32 2.66 25.14 2.22 28.61 0.80 
Creatinine (mg/dL) 0.63 0.02 0.56 0.02 0.60 0.03 0.55 0.03 
Total Bilirubin (mg/dL) 0.24 0.07 0.31 0.04 0.24 0.05 0.33 0.07 
SGOT (IU/L) 100.21 3.00 108.32 3.67 102.82 3.20 103.53 4.54 
SGPT (IU/L) 36.76 1.10 42.98 3.52 40.46 2.28 36.63 1.79 
ALP (U/L) 182.37 9.61 212.99 12.25 200.51 13.86 258.58↑ 25.86 
Total Protein (gm/dL) 6.90 0.13 6.88 0.06 6.94 0.18 6.72 0.14 
Albumin (gm/dL) 4.20 0.13 4.28 0.05 4.26 0.06 4.23 0.09 
Calcium (mg/dL) 11.75 0.15 11.54 0.07 11.77 0.20 11.66 0.14 
Phosphorus (mg/dL) 7.15 0.34 7.07 0.63 5.95 0.36 6.88 0.29 
Sodium (m Eq/l) 150.80 1.77 149.60 0.68 151.00 0.63 152.00 0.41 
Potassium  (m Eq/l) 4.50 0.15 4.74 0.06 4.78 0.27 5.08 0.28 
Chloride (m Eq/l)  109.80 0.37 110.40 0.24 111.60↑ 0.60 109.50 0.50 
Values are in Mean  SEM, ↑=Increased Significant at p<0.05 
 
 
Table 3d — Summary of Biochemistry Parameters: Female Animals Satellite Group 
Parameter 
Group Mean Values - Female 
G1S G4S 
Control 3 mL/kg b. wt. 
Mean SEM Mean SEM 
Blood Glucose (mg/dL) 97.80 3.71 104.92 6.18 
Total Cholesterol (mg/dL) 72.26 2.78 62.50↓ 1.38 
Triglyceride (mg/dL) 52.48 5.77 37.62 5.75 
BUN (mg/dL) 32.48 1.72 34.81 2.02 
Creatinine (mg/dL) 0.59 0.01 0.58 0.02 
Total Bilirubin (mg/dL) 0.71 0.02 0.89↑ 0.08 
SGOT (IU/L) 96.00 2.71 95.64 5.22 
SGPT (IU/L) 49.36 2.83 45.33 2.54 
ALP (U/L) 201.63 10.42 193.34 30.53 
Total Protein (gm/dL) 6.91 0.18 6.84 0.04 
Albumin (gm/dL) 4.23 0.07 4.18 0.04 
Calcium (mg/dL) 11.71 0.12 11.51 0.22 
Phosphorus (mg/dL) 7.97 0.36 7.56 0.28 
Sodium (m Eq/l) 152.00 0.71 153.25 1.70 
Potassium (m Eq/l) 4.16 0.17 4.30 0.13 
Chloride (m Eq/l)  111.60 0.87 114.50 1.44 
Values are in Mean  SEM; ↑=Increased Significant at p<0.05, ↓=Decreased Significant at p<0.05 
 
 
revealed statistical increase in kidney weight (G3). 
The changes were significant either at p<0.05, p<0.01 
levels (Table 4a-b). 
Relative male organ weight revealed statistical 
increase in liver and spleen low dose (G2) group and 
in relative female organ weight adrenal showed 
increase in (G3) and brain (G4S). The changes were 
at p<0.05, p<0.01 levels. Above changes were not in a 




External gross pathological examination of 
moribund sacrificed dead  animals  revealed  swelling  







Table 4a — Summary of Organ Weight (g): Male Animals 
Organ 
Mean Organ Weight (g) 
Sex Male 
Group G1 G2 G3 G4 G1S G4S 
Dose (mL/kg b. wt.) Control 3 6 12 Control Satellite 12 
Mean Fasting Body weight 
Mean 182.146 192.453 195.485 183.242 198.325 205.298 
SEM 10.871 12.401 9.976 4.863 5.925 8.626 
Brain 
Mean 1.577 1.600 1.569 1.518 1.587 1.550 
SEM 0.024 0.100 0.068 0.075 0.021 0.021 
Heart 
Mean 0.734 0.863↑ 0.733 0.715 0.670 0.707 
SEM 0.046 0.026 0.016 0.030 0.037 0.012 
Adrenal 
Mean 0.034 0.034 0.030 0.036 0.040 0.030 
SEM 0.003 0.002 0.006 0.004 0.004 0.002 
Testis 
Mean 2.266 2.570 1.928 2.116 2.208 2.461 
SEM 0.146 0.199 0.376 0.046 0.165 0.073 
Epididymis 
Mean 0.715 0.763 0.646 0.642 0.766 0.787 
SEM 0.067 0.078 0.088 0.017 0.067 0.018 
Kidneys 
Mean 1.251 1.384 1.296 1.279 1.177 1.222 
SEM 0.111 0.076 0.081 0.043 0.130 0.041 
Liver 
Mean 7.317 9.403 7.032 7.052 7.098 7.094 
SEM 0.744 0.678 0.571 0.355 0.425 0.193 
Thymus 
Mean 0.313 0.331 0.297 0.281 0.310 0.365 
SEM 0.023 0.028 0.015 0.037 0.015 0.038 
Spleen 
Mean 0.573 0.966↑↑ 0.398 0.406 0.394 0.468 
SEM 0.066 0.087 0.034 0.027 0.044 0.020 
Values are in Mean  SEM, ↑=Increased Significant at p<0.05, ↑↑=Increased Significant at p<0.01 
 
 
Table 4b — Summary of Organ Weight (g): Female Animals 
Organ 
Mean Organ Weight (g) 
Sex Female 
Group G1 G2 G3 G4 G1S G4S 
Dose (mL/kg b. wt.) Control 3 6 12 Control Satellite 12 
Mean Fasting Body weight 
Mean 160.860 150.542 173.378 154.695 176.242 155.640 
SEM 4.121 3.674 4.660 14.104 6.241 7.219 
Brain 
Mean 1.501 1.479 1.616 1.496 1.693 1.719 
SEM 0.041 0.038 0.065 0.043 0.051 0.050 
Heart 
Mean 0.638 0.636 0.649 0.585 0.749 0.705 
SEM 0.013 0.021 0.027 0.039 0.024 0.059 
Adrenal 
Mean 0.049 0.053 0.035 0.042 0.050 0.046 
SEM 0.006 0.004 0.004 0.005 0.005 0.004 
Ovaries 
Mean 0.077 0.081 0.068 0.069 0.099 0.117 
SEM 0.016 0.012 0.004 0.007 0.018 0.006 
Uterus 
Mean 0.456 0.373 0.534 0.398 0.420 0.613 
SEM 0.059 0.038 0.064 0.044 0.050 0.161 
Kidneys 
Mean 0.968 1.023 1.161↑ 1.053 1.289 1.195 
SEM 0.026 0.059 0.040 0.082 0.049 0.086 
Liver 
Mean 6.851 6.483 7.041 6.402 8.411 7.676 
SEM 0.204 0.421 0.345 0.534 0.510 0.501 
Thymus 
Mean 0.366 0.337 0.382 0.295 0.453 0.377 
SEM 0.024 0.041 0.024 0.044 0.041 0.050 
Spleen 
Mean 0.416 0.366 0.414 0.341 0.489 0.424 
SEM 0.016 0.025 0.013 0.038 0.033 0.035 
Values are in Mean  SEM, ↑=Increased Significant at p<0.05 
 




Table 5a — Summary of Relative Organ Weight (%): Male Animals 
Organ 
Relative Organ Weight (%) 
Sex Male 
Group G1 G2 G3 G4 G1S G4S 
Dose  (mL/kg b. wt.) Control 3 6 12 Control Satellite 12 
Brain 
Mean 0.882 0.848 0.809 0.829 0.803 0.759 
SEM 0.071 0.095 0.055 0.041 0.028 0.035 
Heart 
Mean 0.404 0.452 0.376 0.392 0.337 0.347 
SEM 0.016 0.020 0.011 0.024 0.013 0.018 
Adrenal 
Mean 0.019 0.018 0.016 0.020 0.020 0.015 
SEM 0.001 0.002 0.003 0.002 0.002 0.001 
Testis 
Mean 1.250 1.333 0.974 1.157 1.115 1.207 
SEM 0.061 0.030 0.178 0.030 0.081 0.072 
Epididymis 
Mean 0.391 0.395 0.327 0.351 0.388 0.386 
SEM 0.020 0.021 0.034 0.013 0.039 0.020 
Kidneys 
Mean 0.683 0.721 0.662 0.699 0.590 0.597 
SEM 0.030 0.020 0.010 0.023 0.051 0.024 
Liver 
Mean 3.972 4.920↑ 3.582 3.855 3.586 3.464 
SEM 0.232 0.390 0.130 0.203 0.225 0.080 
Thymus 
Mean 0.172 0.175 0.152 0.154 0.156 0.179 
SEM 0.011 0.022 0.005 0.020 0.005 0.021 
Spleen 
Mean 0.312 0.510↑↑ 0.203 0.222 0.197 0.229 
SEM 0.023 0.060 0.011 0.015 0.016 0.014 
Values are in Mean  SEM; ↑↑=Increased Significant at p<0.01, ↑=Increased Significant at p<0.05 
 
 
Table 5b — Summary of Relative Organ Weight (%): Female Animals 
Organ 
Relative Organ Weight (%) 
Sex Female 
Group G1 G2 G3 G4 G1S G4S 
Dose (mL/kg b. wt.) Control 3 6 12 Control Satellite 12 
Brain 
Mean 0.936 0.984 0.938 0.986 0.963 1.108↑ 
SEM 0.035 0.030 0.060 0.069 0.022 0.036 
Heart 
Mean 0.397 0.423 0.376 0.382 0.425 0.456 
SEM 0.007 0.016 0.019 0.021 0.009 0.043 
Adrenal 
Mean 0.030 0.035 0.020↑ 0.027 0.028 0.030 
SEM 0.004 0.002 0.002 0.002 0.003 0.004 
Ovaries 
Mean 0.047 0.053 0.040 0.047 0.057 0.076 
SEM 0.010 0.008 0.003 0.009 0.011 0.005 
Uterus 
Mean 0.285 0.247 0.307 0.268 0.241 0.398 
SEM 0.038 0.022 0.034 0.046 0.033 0.108 
Kidneys 
Mean 0.602 0.680 0.670 0.686 0.731 0.766 
SEM 0.016 0.036 0.021 0.037 0.008 0.035 
Liver 
Mean 4.274 4.300 4.068 4.150 4.762 4.923 
SEM 0.195 0.233 0.208 0.063 0.178 0.149 
Thymus 
Mean 0.228 0.222 0.220 0.189 0.256 0.241 
SEM 0.017 0.024 0.014 0.016 0.018 0.027 
Spleen 
Mean 0.259 0.242 0.240 0.219 0.278 0.272 
SEM 0.011 0.012 0.009 0.009 0.016 0.019 
Values are in Mean  SEM; ↑=Increased Significant at p<0.05 when compared with G1S 
 
in left forelimb in one female from high dose satellite 
group (animal no. 56) and nasal discharge, swelling in 
upper thoracic region found in one male (animal no. 
41) from control satellite group. Terminally sacrificed 
animals did not reveal any external gross pathological 
findings. Internal (visceral) gross pathological 
examination did not show any abnormalities in both 
the groups, except in following animals: pus 
formation was seen at left forelimb and esophagus 
(animal No 56 female, G4S group) and in upper 
thoracic region of (animal No. 41 male, G1 S group) 
of dead animal along with enlarged adrenal and small 
spleen, diminished testes was observed in animal no 
24 male (G3 group) and animal no 42 (male, G1S 




group), one shrunken kidney and stone were found in 
urinary bladder and all other terminally sacrificed 
animals did not revealed any internal gross 
pathological findings (Table 6).  
 
Histopathological evaluation 
Histopathological investigation carried out in 
organs from all the terminally sacrificed animals (both 
sexes) from control and high dose groups did not 
reveal any evidence of test item related toxicity in any 
of the organs examined except bronchus associated 
lymphoid tissue in lung was observed in one female 
from control group (animal no. 10) which is 
considered as an incidental finding.  
Histopathological evaluation of animals (No. 41, 
56) found moribund/dead animals and tissue sample 
from animals with gross lesions did not show 
abnormal histological features.  
The changes observed in various parameters such 
as body weight, feed consumption, biochemical 
parameters, hematological parameters, organ weight 
and pathology were found inconsistent or not in  
dose dependent manner, hence are not attributed to  
TI administration. 
Janma Ghunti is a traditional polyherbal 
formulation for overall digestive health of babies. The 
therapeutic benefits of individual ingredients 
contribute to the product efficacy synergistically. 
Anjeer (Ficus carica) is a nutritive fruit as per 
Ayurveda. It provides energy as it is a source of 
essential elements like calcium, phosphorus, iron and 
dietary fibers. It also works in constipation as a mild 
laxative, to treat dysentery and enteritis
3
. Vidanga 
(Embelia ribes) is a well-known vermifuge as per 
Ayurvedic literature. It also acts as carminative, 
appetizer and relieves flatulence. E. ribes showed 
potent anthelmintic activity at a concentration of  
10-200 Ug/mL
4
. Palash (Butea monosperma) is an 
appetizer and digestive astringent. It has flavonoids, 
phenolics and alkaloids that possess antioxidant 
activity and nephroprotective activity
5
. Vaca (Acorus 
calamus) is a Medhya rasayana, digestive and 
promotes physical strength and immunity in children. 
It is used traditionally in gastrointestinal disorders 
such as colic pain and diarrhea
6
. Badara (Zizyphus 
jujuba) is good for respiratory health and is a 
digestive stimulant. It has shown anti-fatigue and 
antioxidant activity
7
. Draksha (Vitis vinifera) has 
good nutritional value and also acts as mild laxative, 
appetizer and relieves thirst. It has known anti-
inflammatory and anti-spasmodic effect
8,9
. Madhu 
(honey) improves immunity in children, is good for 
respiratory health and potentiates action and 






Janma Ghunti on oral administration for 28 days 
was found to be nontoxic at the doses of 3, 6 &  
12 mL/kg body weight in both the sexes of wistar rats. 
Based on the study outcome, it may be noted that the 
No Observed Adverse Effect Level (NOAEL) of 
Table 6 — Summary of Gross Pathological Findings 
Organs/ Lesions 
Group G1 G2 G3 G4 G1S G4S 
Dose (mL/kg) Control 3 6 12 Satellite Control 12 
Sex M F M F M F M F M F M F 
No. of Animals 5 5 4 5 4 5 5 4 5 5 4 5 
EXTERNAL 
No abnormalities detected 5 5 4 5 4 5 5 4 4 5 4 4 
Swelling in left forelimb 0 0 0 0 0 0 0 0 0 0 0 1 
Nasal Discharge, Swelling in upper thoracic 
region 
0 0 0 0 0 0 0 0 1 0 0 0 
INTERNAL 
No abnormalities detected 5 5 4 5 3 5 5 4 3 5 4 4 
Pus found under left forlimb and in 
esophagus 
0 0 0 0 0 0 0 0 0 0 0 1 
Pus found in upper thoracic region, enlarge 
adrenal, small spleen 
0 0 0 0 0 0 0 0 1 0 0 0 
Dminished testes 0 0 0 0 1 0 0 0 0 0 0 0 
One kidney shrunken,  
Stone in urinary bladder 
0 0 0 0 0 0 0 0 1 0 0 0 




Janma Ghunti in male and female Wistar rats was 
found to be greater than 12 mL/kg body weight.  
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